| AR | Androgen receptor |
| ALD | Alcoholic liver disease |
| AMPK | AMP-activated protein kinase |
| COX2 | Cyclooxygenease-2 |
| DAA | Direct-acting antivirals |
| DEN | N-diethylnitrosamine |
| DM | Diabetes mellitus |
| EGF | Epidermal growth factor |
| EGFR | Epidermal growth factor receptor |
| GWAS | Genome wide associated studies |
| HBV | Hepatitis B virus |
| HCV | Hepatitis C virus |
| HCC | Hepatocellular carcinoma |
| IFN-α | Interferon alpha |
| LAR | Lysophosphatidic acid receptor |
| LPAR1 | Lysophosphatidic Acid Receptor 1 |
| mTOR | Mammalian target of rapamycin |
| NAFLD | Nonalcoholic fatty liver disease |
| NF-κB | Nuclear factor κB |
| NASH | Nonalcoholic steatohepatitis |
| NSAIDS | Nonsteroidal anti-inflammatory drugs |
| PPAR | Peroxisome proliferator activated receptors |
| PLS | Prognostic liver signature |
| ROS | Reactive oxygen species |
| SNP | Single nucleotide polymorphism |
| SVR | Sustained virologic response |
| TNF-a | Tumor-Necrosis-Factor alpha |